Neurology

Alzheimer’s experts greet China’s surprise approval of a drug for brain disease with hope and caution

A Chinese biotech startup has startled neuroscientists and drug developers with a new plant-based compound it claims improves cognitive function in Alzheimer’s patients by altering their gut microbiomes.

Source link




Related posts

The Robert Yates Charitable Fund donates $100K to the UF Trauma, Concussion & Sports Medicine Program

Newsemia

Judging Informed Consent

Newsemia

How marijuana affects the body

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy